Who invested in Attralus

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$56Mraised across 1 round since 2024, from 1 source

Latest round: Series B, $56MFeb 2024
Investors: 4

See who backed them

The rounds

Feb 2024
Series B$56M
Source recordedSEC filing: $56M sold, first sale Jan 2024

Founders and team

From Attralus's own website and the SEC filings it signed: 8 on the team.

Glen FirestonePresident, Chief Business Officer
Mark TimneyChief Executive Officer
Karen RobertsonVice President, Regulatory Affairs
James TestaVice President, Finance
Christine HuhHead Of Human Resources
Gregory BellExecutive Officeri
Mehdi KhodadadExecutive Officeri
Spencer GuthrieExecutive Officeri

On the board, as filediAlex DennerCorey GoodmanJake BauerNancy Miller-RichRahul KakkarRichard Gaster

Everyone who backed them

Janus Henderson InvestorsPrivate equity1round

Vivo CapitalPrivate equity1round

Redmile GroupVC firm1round

Samsara BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Attralus as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.